R&D funding select diseases worldwide 2021

This statistic shows the global R&D funding granted by institutions to finance the fight against selected diseases in 2021. In that year, there were some 1.47 billion U.S. dollars provided for R&D specifically for the fight against HIV/AIDS.

Donated funds for research and development by disease in 2021 (in million U.S. dollars)

Characteristic	Funding in million U.S. dollars
Total	4,137
HIV/AIDS	1,466
Tuberculosis	723
Malaria	626
Diarrhoeal diseases	136
Kinetoplastids	130
Worms and flukes	86
Dengue fever	78
Salmonella infections	71
Bacterial pneunomia/meningitis	64
Snakebite envenoming	18
Hepatitis C	16
Hepatitis B	16
Cryptococcal meningitis	14
Rheumatic fever	9.2
Leprosy	6.8
Histoplasmosis	3.6
Scabies	2
Mycetoma	0.8
Trachoma	0.7
Buruli ulcer	0.6
Leptospirosis	0.1
Platform technologies	146
Multi-disease vector control products	75
Core funding of a multidisease R&D organization	378
Other R&D	70

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

January 2023

More information

Region

Worldwide

Survey time period

2021

Supplementary notes

Figures are in constant 2021 U.S. dollars.
Please note that some of the diseases listed above are actually groups of diseases, such as the diarrhoeal illnesses and helminth infections. This reflects common practice and also the shared nature of research in some areas. For example: Streptococcus pneumoniae R&D is often targeted at both pneumonia and meningitis.

Open this statistic in...

Spanish

Citation formats